Abstract
Erythema nodosum is the most frequent clinicopathological variant of the panniculitides. The disorder is a cutaneous reaction consisting of inflammatory nodular lesions, usually located on the lower extremities. It may be associated with a wide variety of diseases, infections, sarcoidosis, rheumatologic diseases, inflammatory bowel diseases, medications and malignancies. Relationship between erythema nodosum and malignant lymphoma is described in the article. A review of the literature suggest that the diagnosis of Hodgkin's and non-Hodgkin's disease should be considered in patients with unexplained erythema nodosum.
Publication types
-
Comparative Study
-
English Abstract
-
Review
MeSH terms
-
Adult
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Child
-
Cyclophosphamide / therapeutic use
-
Diagnosis, Differential
-
Doxorubicin / therapeutic use
-
Erythema Induratum / diagnosis
-
Erythema Nodosum / complications
-
Erythema Nodosum / diagnosis
-
Erythema Nodosum / etiology*
-
Erythema Nodosum / therapy
-
Etoposide / therapeutic use
-
Female
-
Hodgkin Disease / complications*
-
Hodgkin Disease / diagnosis
-
Hodgkin Disease / drug therapy
-
Humans
-
Lymphoma, B-Cell / complications
-
Lymphoma, B-Cell / diagnosis
-
Lymphoma, B-Cell / drug therapy
-
Lymphoma, Non-Hodgkin / complications*
-
Lymphoma, Non-Hodgkin / diagnosis
-
Lymphoma, Non-Hodgkin / drug therapy
-
Male
-
Middle Aged
-
Paraneoplastic Syndromes*
-
Prednisolone / therapeutic use
-
Prednisone / therapeutic use
-
Pregnancy
-
Procarbazine / therapeutic use
-
Remission Induction
-
Vincristine / therapeutic use
Substances
-
Procarbazine
-
Vincristine
-
Etoposide
-
Doxorubicin
-
Cyclophosphamide
-
Prednisolone
-
Prednisone
Supplementary concepts
-
CHOEP protocol
-
COPP protocol